Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
1356905-39-9[2H]c1c([2H])c([2H])c(CC[C@@H](N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O)C(=O)O)c([2H])c1[2H]RLAWWYSOJDYHDC-XIPFODBISA-N1356905-39-9DTXSID301363977BeschreibungLisinopril-d5 is intended for use as an internal standard for the quantification of lisinopril by GC- or LC-MS. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM). It reduces the formation of endothelin-1 and increases nitric oxide in human vascular endothelial cells. Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 μg/kg in rat and dog, respectively).
Verwenden(S)Lisinopril-D5 can be Labeled , it is an orally active angiotensin-converting enzyme (ACE) inhibitor , intended for use as an internal standard for the quantification of Lisinopril by GC- or LC-mass spectrometry.
Wird geladen…
Wird geladen…
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…